MD Newsline Dermatology Brief omslagsbild

MD Newsline Dermatology Brief

MD Newsline Dermatology Brief

Av: MD Newsline
Lyssna kostnadsfritt nu, utan abonnemang

Das größte Angebot der Saison | 0,99 € pro Monat für die ersten 3 Monate + 15 € Audible-Guthaben

Danach 6,99 €/Monat. Bedingungen gelten. Monatlich kündbar.
Om den här titeln
Welcome to MD Newsline Dermatology Brief, your trusted source for concise, expert-led updates in the evolving field of dermatology. Designed for busy healthcare professionals, this podcast delivers focused insights from leading dermatologists, researchers, and clinical experts. Each episode explores the latest in skin health, including cutting-edge research, emerging treatments, and practical strategies for managing conditions such as eczema, psoriasis, urticaria, and atopic dermatitis. From advances in biologics to real-world patient care approaches, we simplify complex topics into clear, actionable takeaways. Whether you're a dermatologist, physician, or part of the broader medical community, Dermatology Brief helps you stay informed without the noise. Our mission is to provide timely, relevant knowledge that supports better clinical decisions and improved patient outcomes. Tune in for quick, impactful insights shaping the future of dermatologic care.2026 Hygiene & gesundes Leben
Avsnitt
  • Personalizing Atopic Dermatitis Management
    Oct 20 2026
    In this episode of MD Newsline, Kendra Joseph, PA-C, a dermatology physician assistant with over ten years of clinical experience in New York City, breaks down the complexities of managing atopic dermatitis (AD) and the broader eczema umbrella. She clarifies the differences between atopic dermatitis and related conditions like seborrheic dermatitis and contact dermatitis. Joseph addresses the clinical nuances of diagnosing AD across diverse patient populations, focusing on non-classical presentations in skin of color—such as violaceous or hyperpigmented lesions—and the psychological toll of chronic pruritus. The discussion covers practical management strategies for scalp eczema, contrasting over-the-counter oil use with targeted prescription vehicles matched to specific hair textures and styling routines. Finally, she examines the shift from broad topical corticosteroids to targeted topical JAK inhibitors, calcineurin inhibitors, oral JAK inhibitors, and biologics, highlighting the importance of collaborative care, mental health support, and emerging precision medicine. Episode Highlights Demystifying the Eczema Umbrella and Clinical Presentations Kendra Joseph, PA-C, clarifies that eczema serves as an umbrella term covering various inflammatory skin conditions. Atopic dermatitis represents the most common variant, classically presenting on flexural surfaces such as the back of the knees, antecubital fossa, and neck. It frequently co-occurs alongside asthma and seasonal allergies as part of the atopic triad. In clinical practice, key diagnostic features include lesion distribution, recurrence in identical locations, seasonal flare cycles, and generalized itching. Joseph notes that while AD is often mischaracterized as purely a childhood disease, many adult patients present with new-onset atopic dermatitis. Navigating Diagnostic Nuances in Skin of Color and Scalp Care The conversation addresses diagnostic and therapeutic considerations for diverse skin types and hair textures. In darker skin types, AD lesions often present with violaceous (purplish) hues or post-inflammatory hyperpigmentation rather than classic erythema. On the scalp, AD must be differentiated from seborrheic dermatitis. Joseph cautions against applying heavy over-the-counter oils, as common yeast species on the scalp feed on these products and exacerbate inflammation. Instead, clinicians should match prescription vehicles—such as oil-based topicals or lightweight solutions—to a patient's specific hair-styling practices and texture. Addressing the Burden of Pruritus, Sleep Loss, and Secondary Infections Beyond visible skin lesions, pruritus imposes a severe physical and psychological burden, leading to sleep disruption, missed work, and social withdrawal. Chronic scratching leads to lichenification (thickened, leathery skin). Clinicians must remain vigilant for secondary superinfections, including impetiginized skin characterized by yellow, honey-colored crusting, as well as eczema herpeticum, which presents with painful blisters, fever, and systemic malaise. Skin Barrier Repair, Emollients, and Flare Trigger Management Optimal management requires pairing prescription therapies with rigorous, personalized skincare routines. Patients should utilize fragrance-free cleansers and thick emollients containing humectants, glycerin, hyaluronic acid, or ceramides immediately after short, lukewarm showers to restore skin barrier integrity. Trigger reduction—including identifying specific metal allergens like nickel in contact dermatitis—should be managed collaboratively to avoid unnecessary lifestyle restrictions. Therapeutic Escalation: Topicals, Biologics, JAK Inhibitors, and Phototherapy While topical corticosteroids remain a fast-acting option to extinguish acute flares, clinicians must address patient anxiety around steroid overuse or misuse. Non-steroidal topicals, including topical JAK inhibitors and topical calcineurin inhibitors, provide effective alternatives. When AD severely impacts quality of life or affects large body surface areas, care escalates to systemic biologics, oral JAK inhibitors, or phototherapy (narrowband UVB light therapy) for patients seeking non-pharmacological options. Multidisciplinary Collaboration, Mental Health, and Future Horizons Managing chronic AD requires addressing the psychological sequelae of long-term disease. Joseph advocates for involving psychologists, therapists, allergists, and primary care providers when patients experience disease-related anxiety or burnout. Looking to the future, she highlights the promise of precision medicine to select therapies based on individual genetic profiles and anticipates ongoing advancements toward higher disease clearance rates. Key Takeaway Managing atopic dermatitis requires a comprehensive, patient-centered approach that extends beyond treating surface lesions to address chronic pruritus, skin barrier ...
    Visa mer Visa mindre
    31 min
  • Understanding Atopic Dermatitis Beyond Dry Skin
    Oct 13 2026
    In this episode of MD Newsline, Dr. Marisa Garshick, a board-certified dermatologist at Medical Dermatology and Cosmetic Surgery Center in New York and Clinical Assistant Professor at Weill Cornell Medicine, discusses modern clinical approaches to atopic dermatitis (AD). Dr. Garshick reframes atopic dermatitis from simple "dry skin" to a complex, chronic type 2 inflammatory disease. She highlights the diagnostic nuances across different skin tones, the biological mechanics of the atopic march, and the profound impact of pruritus on sleep architecture, mental health, and patient quality of life. The conversation explores practical barrier care, Staphylococcus aureus colonization, bleach baths, the skin microbiome, and the clinical distinction between true food allergies and eczema flares. Dr. Garshick also details the therapeutic paradigm shift from broad immunosuppressive medications and traditional topical steroids to targeted biologics, JAK inhibitors, non-steroidal topicals, and phototherapy. Episode Highlights Reframing Atopic Dermatitis and Diagnostic Nuances Dr. Garshick emphasizes that atopic dermatitis is a chronic inflammatory skin condition requiring more than over-the-counter moisturizers to heal properly. While classic presentations involve erythematous, pink scaly patches in flexural areas like the antecubital fossa or popliteal fossa, atopic dermatitis in skin of color can present non-classically as dark brown, purple, or ashen gray patches. When clinical presentation is unclear, a skin biopsy should be performed for histopathological confirmation. Differentiating Adult-Onset Disease and the Atopic March When evaluating adult-onset atopic dermatitis, clinicians must rule out lookalike conditions such as contact dermatitis triggered by fragrances or preservatives. Dr. Garshick also addresses the atopic march—the progression from atopic dermatitis to asthma and allergic rhinitis—reassuring clinicians and parents that while genetic predisposition elevates overall risk, progression across all conditions is not inevitable for every patient. Type 2 Inflammation, Systemic Burden, and Mental Health The discussion highlights how atopic dermatitis is driven by type 2 inflammatory pathways and specific cytokine pathways that impair skin barrier integrity and drive central itch signaling. The resulting pruritus causes profound sleep disruption, cutaneous pain (burning or stinging sensations), and elevated rates of anxiety and depression. Managing the underlying cutaneous inflammation is critical to improving overall sleep quality and psychological well-being. Microbiome Dynamics, Infection Control, and Bleach Baths Barrier disruption from scratching allows opportunistic pathogens like Staphylococcus aureus to colonize the skin, triggering recurrent secondary bacterial or viral infections and driving flare-ups. Dr. Garshick explains the role of bleach baths (dilute sodium hypochlorite baths using a quarter-cup of bleach) as an effective method for bacterial decolonization. She also reviews the emerging role of prebiotics, probiotics, and postbiotics in supporting the skin microbiome alongside standard barrier repair. Dietary Misconceptions vs. True Food Allergies Dr. Garshick addresses common patient misunderstandings surrounding diet and atopic dermatitis. Unnecessary elimination diets can harm growing children, as true food allergies typically manifest as immediate urticaria (hives) rather than eczematous patches. While high glycemic index foods and highly processed carbohydrates may promote generalized inflammation, clinicians should encourage a well-balanced diet rather than blanket food restrictions. Evolving Therapeutic Options: From Topicals to Targeted Systemics The therapeutic landscape for atopic dermatitis has expanded significantly beyond broad immunosuppressive medications. Management ranges from daily emollient barrier maintenance to phototherapy and advanced targeted therapies, including biologics, JAK inhibitors, and non-steroidal topical agents. Dr. Garshick underscores the importance of maintaining proactive maintenance therapy to sustain disease remission rather than reactively treating flares after barrier breakdown occurs. Key Takeaway Effective management of atopic dermatitis requires moving beyond simple moisturizers to address underlying type 2 inflammation, restore skin barrier integrity, and suppress pruritus. Utilizing targeted therapies—such as biologics, JAK inhibitors, non-steroidal topicals, and proper decolonization protocols—allows clinicians to achieve long-term disease remission and significantly improve patient quality of life. RESOURCES Website — https://mdnewsline.com/ Newsletter — https://mdnewsline.com/subscribe/ Dr. Marisa Garshick — https://weillcornell.org/marisa-garshick-md Medical Dermatology and Cosmetic Surgery Center (MDCS Dermatology) — https://mdcsderm.com/ Weill Cornell Medicine ...
    Visa mer Visa mindre
    34 min
  • Understanding Atopic Dermatitis Beyond Dry Skin ft. Dr. Marisa Garshick
    Aug 28 2026
    In this episode of MD Newsline, Dr. Marisa Garshick, board-certified dermatologist at Medical Dermatology & Cosmetic Surgery and Clinical Assistant Professor of Dermatology at Weill Cornell Medicine, discusses why atopic dermatitis is far more than dry skin. She explores how eczema can present differently across skin tones, the challenges of distinguishing atopic dermatitis from other inflammatory skin conditions, and why visible disease severity does not always reflect the impact of symptoms on patients. Dr. Garshick also shares practical insights into skincare fundamentals, treatment selection, targeted therapies, the role of the skin microbiome, and strategies for improving long-term disease control. She discusses the impact of itch on sleep, mental health, and daily functioning, as well as emerging approaches to prevention and the future of atopic dermatitis care. Episode Highlights: Recognizing Atopic Dermatitis Beyond Dry Skin Dr. Garshick explains that atopic dermatitis is more than simple dry skin and includes an inflammatory component that may require more than moisturization alone. She discusses common clinical features, including itchy, scaly patches and characteristic distributions such as the inner arms and backs of the knees, while emphasizing the importance of considering other diagnoses when evaluating adult-onset disease. Diagnosing Eczema Across Different Skin Tones The conversation explores how atopic dermatitis can look different across skin tones and why clinicians should remain attentive to less-classical presentations. Dr. Garshick discusses the importance of clinical evaluation and notes that a skin biopsy may help when the diagnosis is uncertain. Disease Severity, Itch, and Quality of Life Dr. Garshick discusses how the extent and thickness of skin lesions can contribute to assessments of severity, but emphasizes that even mild visible disease can have a substantial impact on patients. Persistent itch can disrupt sleep, work, school, and daily functioning, making quality of life an important consideration when evaluating disease control and treatment needs. The Atopic March and Allergic Disease Dr. Garshick explains the concept of the atopic march and the potential relationship between eczema, asthma, and allergic rhinitis. She emphasizes that an atopic predisposition does not mean every patient will develop all of these conditions, while highlighting the importance of remaining attentive to potential allergic disease, particularly in individuals with a relevant family history. Advances in Targeted Atopic Dermatitis Therapies The discussion explores how a better understanding of the immune mechanisms involved in atopic dermatitis has led to more targeted treatment approaches. Dr. Garshick discusses the evolution from broader immunosuppressive therapies toward targeted immune therapies, including biologics and JAK inhibitors, and how these options have expanded the ability to achieve disease control. Skin Barrier Care and Treatment Adherence Dr. Garshick emphasizes that moisturization and skin barrier support remain foundational to atopic dermatitis management, even with newer medical therapies. She shares practical recommendations including short, lukewarm showers, regular use of moisturizer, and selecting products that patients are comfortable using consistently. She also discusses fragrance-free products and barrier-supporting ingredients such as ceramides, hyaluronic acid, and niacinamide. The Skin Microbiome, Infections, and Flares The conversation examines how disruption of the skin barrier can increase opportunities for bacterial and viral infections and contribute to recurring problems in some patients. Dr. Garshick discusses the importance of maintaining the skin barrier and explains that approaches such as antibacterial washes or bleach baths may be considered in certain patients with recurrent infections. She also discusses the growing interest in the skin microbiome, while noting that more research is needed to determine how microbiome-directed approaches will fit into future eczema care. Diet, Food Allergies, and Atopic Dermatitis Dr. Garshick addresses common questions surrounding diet and eczema, explaining that most patients do not need to follow a specific elimination diet. She discusses situations in which a food diary may help identify a potential relationship between a particular food and flares, while cautioning against unnecessary food restriction and noting that food allergy reactions can present differently from typical eczema. Long-Term Management and Emerging Therapies Dr. Garshick discusses the role of phototherapy for selected patients, as well as emerging approaches to prevention and maintenance therapy. She highlights data supporting early moisturization in some infants with a strong family history of allergic disease and emphasizes the goal of maintaining remission rather than simply treating flares after they occur. Looking ahead, she expects ...
    Visa mer Visa mindre
    34 min
adbl_web_anon_alc_button_suppression_t1
Inga recensioner ännu